ST. PAUL, MN -- (MARKET WIRE) -- February 26, 2007 -- GelStat Corporation (PINKSHEETS: GSAC), a consumer healthcare company primarily focused on the development and marketing of over-the-counter (OTC) products for the safe and effective treatment of pain and inflammation, is announcing that its patented migraine treatment “GelStat™Migrane” has been selected to be included in two mail order catalogs that will be sent to approximately ten million households in April of 2007.
